---
document_datetime: 2023-09-21 18:31:40
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/mycophenolate-mofetil-teva-epar-all-authorised-presentations_en.pdf
document_name: mycophenolate-mofetil-teva-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0491589
conversion_datetime: 2025-12-23 21:43:07.889775
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name            | Strength   | Pharmaceutical form   | Route of administration   | Immediate Packaging      | Pack size                    |
|------------------|----------------------------|------------|-----------------------|---------------------------|--------------------------|------------------------------|
| EU/1/07/439/001  | Mycophenolate mofetil Teva | 250 mg     | Capsule, hard         | Oral use                  | Blister (PVC/PVdC/Al u ) | 100 capsules                 |
| EU/1/07/439/002  | Mycophenolate mofetil Teva | 250 mg     | Capsule, hard         | Oral use                  | Blister (PVC/PVdC/Al u ) | 300 capsules                 |
| EU/1/07/439/003  | Mycophenolate mofetil Teva | 500 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVdC/Al u ) | 50 tablets                   |
| EU/1/07/439/004  | Mycophenolate mofetil Teva | 500 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVdC/Al u ) | 150 tablets                  |
| EU/1/07/439/005  | Mycophenolate mofetil Teva | 500 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVdC/Al u ) | 50 x 1 tablets (unit dose)   |
| EU/1/07/439/006  | Mycophenolate mofetil Teva | 250 mg     | Capsule, hard         | Oral use                  | Blister (PVC/PVdC/Al u ) | 100 x 1 capsules (unit dose) |